Abstract:Background: Significant progress has been made over the past decade in measuring the chemical components of the exposome, providing transformative population-scale frameworks in probing the etiologic link between environmental factors and disease phenotypes. While the analytical technologies continue to evolve with reams of data being generated, there is an opportunity to complement exposome-wide association studies (ExWAS) with functional analyses to advance etiologic search at organismal, cellular, and molecular levels. Objectives: Exposomics is a transdisciplinary field aimed at enabling discovery-based analysis of the nongenetic factors that contribute to disease, including numerous environmental chemical stressors. While advances in exposure assessment are enhancing population-based discovery of exposome-wide effects and chemical exposure agents, functional screening and elucidation of biological effects of exposures represent the next logical step toward precision environmental health and medicine. In this work, we focus on the use, strategies, and prospects of alternative approaches and model systems to enhance the current human exposomics framework in biomarker search and causal understanding, spanning from bench-based nonmammalian organisms and cell culture to computational new approach methods (NAMs). Discussion: We visit the definition of the functional exposome and exposomics and discuss a need to leverage alternative models as opposed to mammalian animals for delineating exposome-wide health effects. Under the "three Rs" principle of reduction, replacement, and refinement, model systems such as roundworms, fruit flies, zebrafish, and induced pluripotent stem cells (iPSCs) are advantageous over mammals (e.g., rodents or higher vertebrates). These models are cost-effective, and cell-specific genetic manipulations in these models are easier and faster, compared to mammalian models. Meanwhile, in silico NAMs enhance hazard identification and risk assessment in humans by bridging the translational gaps between toxicology data and etiologic inference, as represented by in vitro to in vivo extrapolation (IVIVE) and integrated approaches to testing and assessment (IATA) under the adverse outcome pathway (AOP) framework. Together, these alternatives offer a strong toolbox to support functional exposomics to study toxicity and causal mediators underpinning exposure-disease links. https://doi.org/10.1289/EHP13120.

Prospects and challenges of multi-omics data integration in toxicology

Evaluating the performance of multi-omics integration: a thyroid toxicity case study

Multi-omics integration analysis: Tools and applications in environmental toxicology

Systematic Review of Multi-Omics Approaches to Investigate Toxicological Effects in Macrophages

Research progress in drug toxicology based on systems biology

Are we forgetting the "proteomics" in multi-omics ecotoxicology?

Systems toxicology: applications of toxicogenomics, transcriptomics, proteomics and metabolomics in toxicology

Metabonomics: its potential as a tool in toxicology for safety assessment and data integration

Progress and promises in toxicogenomics in aquatic toxicology: Is technical innovation driving scientific innovation?

Statistical Single Cell Multi-Omics Integration

Progress in toxicogenomics to protect human health

Navigating the bridge between wet and dry lab toxicology research to address current challenges with high-dimensional data

Survey on Multi-omics, and Multi-omics Data Analysis, Integration and Application

In Pursuit of Effective Toxicogenomics

Seminar: Functional Exposomics and Mechanisms of Toxicity-Insights from Model Systems and NAMs

ESR 12: Transcriptomics, metabolomics, and toxicity pathway analysis of combined exposure to neurotoxicants: transcriptomic statistical method development

Integration of Computational Toxicology, Toxicogenomics Data Mining, and Omics Techniques to Unveil Toxicity Pathways

Combining biomarkers of susceptibility with toxicodynamic models: a novel approach for assessing modifying factors

Prospects for Applying Synthetic Biology to Toxicology: Future Opportunities and Current Limitations for the Repurposing of Cytochrome P450 Systems

Using transcriptomics, proteomics and phosphoproteomics as new approach methodology (NAM) to define biological responses for chemical safety assessment